Literature DB >> 22005911

Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010.

R de Marco1, V Cappa, S Accordini, M Rava, L Antonicelli, O Bortolami, M Braggion, M Bugiani, L Casali, L Cazzoletti, I Cerveri, A G Fois, P Girardi, F Locatelli, A Marcon, A Marinoni, M G Panico, P Pirina, S Villani, M E Zanolin, G Verlato.   

Abstract

The prevalence of asthma increased worldwide until the 1990s, but since then there has been no clear temporal pattern. The present study aimed to assess time trends in the prevalence of current asthma, asthma-like symptoms and allergic rhinitis in Italian adults from 1990 to 2010. The same screening questionnaire was administered by mail or phone to random samples of the general population (age 20-44 yrs) in Italy, in the frame of three multicentre studies: the European Community Respiratory Health Survey (ECRHS) (1991-1993; n = 6,031); the Italian Study on Asthma in Young Adults (ISAYA) (1998-2000; n = 18,873); and the Gene Environment Interactions in Respiratory Diseases (GEIRD) study (2007-2010; n = 10,494). Time trends in prevalence were estimated using Poisson regression models in the centres that repeated the survey at different points in time. From 1991 to 2010, the median prevalence of current asthma, wheezing and allergic rhinitis increased from 4.1% to 6.6%, from 10.1% to 13.9% and from 16.8% to 25.8%, respectively. The prevalence of current asthma was stable during the 1990s and increased (relative risk 1.38, 95% CI 1.19-1.59) from 1998-2000 to 2007-2010, mainly in subjects who did not report allergic rhinitis. The prevalence of allergic rhinitis has increased continuously since 1991. The asthma epidemic is not over in Italy. During the past 20 yrs, asthma prevalence has increased by 38%, in parallel with a similar increase in asthma-like symptoms and allergic rhinitis.

Entities:  

Mesh:

Year:  2011        PMID: 22005911     DOI: 10.1183/09031936.00061611

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  84 in total

1.  Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.

Authors:  Rosalind M Eggo; James G Scott; Alison P Galvani; Lauren Ancel Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

2.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 3.  Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients.

Authors:  Hoang Kim Tu Trinh; Ga-Young Ban; Ji-Ho Lee; Hae-Sim Park
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

4.  Characteristics and predictors of allergic rhinitis undertreatment in primary care.

Authors:  F Spinozzi; N Murgia; S Baldacci; S Maio; A P Pala; C Casciari; M dell'Omo; G Viegi
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-17       Impact factor: 3.219

5.  Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions.

Authors:  Giovanni Rolla; Sabrina Mietta; Alberto Raie; Claudia Bussolino; Franco Nebiolo; Maurizio Galimberti; Gianni Cadario; Enrico Heffler
Journal:  Intern Emerg Med       Date:  2013-07-13       Impact factor: 3.397

6.  Late-Onset Asthma: A Diagnostic and Management Challenge.

Authors:  Charlotte Suppli Ulrik
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

7.  Comparison of clinical characteristics and management of asthma by types of health care in South Korea.

Authors:  Eun Yeong Cho; Ki Jong Oh; Chin Kook Rhee; Kwang Ha Yoo; Bo Yeon Kim; Hye Won Bae; Byung-Jae Lee; Dong-Chull Choi; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

8.  Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.

Authors:  Giorgio Walter Canonica; Francesco Blasi; Nunzio Crimi; Pierluigi Paggiaro; Alberto Papi; Francesca Fanelli; Annalisa Stassaldi; Gianluca Furneri
Journal:  Clin Mol Allergy       Date:  2021-05-21

9.  Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study.

Authors:  Giorgio Walter Canonica; Giorgio Lorenzo Colombo; Paola Rogliani; Pierachille Santus; Claudia Pitotti; Sergio Di Matteo; Chiara Martinotti; Giacomo Matteo Bruno
Journal:  Risk Manag Healthc Policy       Date:  2020-01-22

10.  Oral Administration of Zataria multiflora Extract Decreases IL-17 Expression in Perennial Allergic Rhinitis.

Authors:  Nazila Ariaee; Jalal Ghorbani; Maryam Panahi; Mojgan Mohamadi; Javad Asili; Alireza Ranjbar; Reza Farid Hoseini; Farahzad Jabbari
Journal:  Rep Biochem Mol Biol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.